Pfizer announced the $100 million acquisition of RezApp, a Brisbane-based startup that claims to detect COVID-19 by analyzing the sound of a user's cough. The app reportedly has 92% sensitivity but is only 50% accurate for asymptomatic users. The hosts dismiss the technology as "bullshit" and suggest it will be used for future surveillance.
